| Eugene Curley, MD | |
|
1001 S George St, 4th Floor Mkb, York, PA 17403-3676 | |
| (717) 851-2417 | |
| (717) 851-3712 |
| Full Name | Eugene Curley |
|---|---|
| Gender | Male |
| Speciality | Infectious Disease |
| Experience | 20 Years |
| Location | 1001 S George St, York, Pennsylvania |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1356556070 | NPI | - | NPPES |
| 102489181 | Medicaid | PA | |
| 30079290 | Other | PA | AMERIHEALTH MERCY-WMG |
| 965757 | Other | MD | CAREFIRST MD BCBS |
| 301600 | Other | PA | UNISON |
| 2507496 | Other | PA | HIGHMARK BLUE SHILD-WMG |
| 301600 | Other | PA | UNISON-WMG |
| 1591277 | Other | PA | GATEWAY-WMG |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RI0200X | Internal Medicine - Infectious Disease | MD439632 (Pennsylvania) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Wellspan Vna Home Care | York, PA | Home health agency |
| York Hospital | York, PA | Hospital |
| Gettysburg Hospital | Gettysburg, PA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Wellspan Medical Group | 1951213115 | 1946 |
News Archive
In May 2000, Raul Silva was involved in a motorcycle accident in Baja California, Mexico, badly breaking his left femur, or thighbone. He underwent emergency surgery in Mexicali and, at first, everything seemed fine. Then an infection set in, worsened, and Silva eventually made his way to San Diego, where his left leg was amputated.
Trubion Pharmaceuticals, Inc. today announced favorable safety and efficacy data following administration of a second course (R2) of re-treatment with 800 mg of TRU-015 for rheumatoid arthritis (RA). These data are the latest results from the ongoing open-label re-treatment portion of the Phase 2b (15002) RA study of TRU-015. Pfizer Inc. and Trubion are collaborating on the development of TRU-015 for the treatment of autoimmune and inflammatory diseases, including RA.
Scientists from Biodel Inc. reported new findings from the company's Linjeta, insulin glargine, "smart" basal insulin and stabilized glucagon development programs in poster presentations yesterday and today at the Tenth Annual Diabetes Technology Meeting in Bethesda, MD.
New research may allow new, more effective and safer pain medications to reach patients who suffer from chronic pain sooner. According to a recent study published in Anesthesiology, the official medical journal of the American Society of Anesthesiologists, using functional magnetic resonance imaging (FMRI), to measure the brain's neural response to pain, may be a viable tool for evaluating the effectiveness of new pain medications during the early stages of human drug development - providing the needed objective evidence to prevent the premature discarding of potentially beneficial therapies.
› Verified 1 days ago
| Entity Name | Wellspan Medical Group |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1750480299 PECOS PAC ID: 1951213115 Enrollment ID: O20040220000815 |
News Archive
In May 2000, Raul Silva was involved in a motorcycle accident in Baja California, Mexico, badly breaking his left femur, or thighbone. He underwent emergency surgery in Mexicali and, at first, everything seemed fine. Then an infection set in, worsened, and Silva eventually made his way to San Diego, where his left leg was amputated.
Trubion Pharmaceuticals, Inc. today announced favorable safety and efficacy data following administration of a second course (R2) of re-treatment with 800 mg of TRU-015 for rheumatoid arthritis (RA). These data are the latest results from the ongoing open-label re-treatment portion of the Phase 2b (15002) RA study of TRU-015. Pfizer Inc. and Trubion are collaborating on the development of TRU-015 for the treatment of autoimmune and inflammatory diseases, including RA.
Scientists from Biodel Inc. reported new findings from the company's Linjeta, insulin glargine, "smart" basal insulin and stabilized glucagon development programs in poster presentations yesterday and today at the Tenth Annual Diabetes Technology Meeting in Bethesda, MD.
New research may allow new, more effective and safer pain medications to reach patients who suffer from chronic pain sooner. According to a recent study published in Anesthesiology, the official medical journal of the American Society of Anesthesiologists, using functional magnetic resonance imaging (FMRI), to measure the brain's neural response to pain, may be a viable tool for evaluating the effectiveness of new pain medications during the early stages of human drug development - providing the needed objective evidence to prevent the premature discarding of potentially beneficial therapies.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Eugene Curley, MD 1803 Mount Rose Ave, Suite B3, York, PA 17403-3026 Ph: (717) 851-1405 | Eugene Curley, MD 1001 S George St, 4th Floor Mkb, York, PA 17403-3676 Ph: (717) 851-2417 |
News Archive
In May 2000, Raul Silva was involved in a motorcycle accident in Baja California, Mexico, badly breaking his left femur, or thighbone. He underwent emergency surgery in Mexicali and, at first, everything seemed fine. Then an infection set in, worsened, and Silva eventually made his way to San Diego, where his left leg was amputated.
Trubion Pharmaceuticals, Inc. today announced favorable safety and efficacy data following administration of a second course (R2) of re-treatment with 800 mg of TRU-015 for rheumatoid arthritis (RA). These data are the latest results from the ongoing open-label re-treatment portion of the Phase 2b (15002) RA study of TRU-015. Pfizer Inc. and Trubion are collaborating on the development of TRU-015 for the treatment of autoimmune and inflammatory diseases, including RA.
Scientists from Biodel Inc. reported new findings from the company's Linjeta, insulin glargine, "smart" basal insulin and stabilized glucagon development programs in poster presentations yesterday and today at the Tenth Annual Diabetes Technology Meeting in Bethesda, MD.
New research may allow new, more effective and safer pain medications to reach patients who suffer from chronic pain sooner. According to a recent study published in Anesthesiology, the official medical journal of the American Society of Anesthesiologists, using functional magnetic resonance imaging (FMRI), to measure the brain's neural response to pain, may be a viable tool for evaluating the effectiveness of new pain medications during the early stages of human drug development - providing the needed objective evidence to prevent the premature discarding of potentially beneficial therapies.
› Verified 1 days ago
Robert A Fritz, DO Infectious Disease Medicare: Not Enrolled in Medicare Practice Location: 1777 5th Ave, York, PA 17403 Phone: 717-843-8051 Fax: 717-846-0721 | |
Dr. Aruna Chelliah, MD Infectious Disease Medicare: Not Enrolled in Medicare Practice Location: 292 Saint Charles Way, York, PA 17402 Phone: 717-851-6231 Fax: 717-741-1719 | |
Ali Abbas, MD Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 2690 Southfield Dr Ste A, York, PA 17403 Phone: 717-741-1414 Fax: 717-741-4774 | |
Amna Chaudary, MD Infectious Disease Medicare: Medicare Enrolled Practice Location: 1001 S George St, York, PA 17403 Phone: 717-741-8003 Fax: 717-741-8016 | |
Dr. Iain Lewis Mackenzie, M.D. Infectious Disease Medicare: Not Enrolled in Medicare Practice Location: 25 Monument Road Suite 250, Apple Hill Medical Center Digestive Disease Center, York, PA 17403 Phone: 717-741-9344 Fax: 717-741-9633 | |
Johat Aponte, MD Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 1701 Innovation Dr, York, PA 17408 Phone: 717-843-8623 Fax: 717-815-2489 | |
Manuel Jose Rovira Gonzalez, Infectious Disease Medicare: Medicare Enrolled Practice Location: 1001 S George St, York, PA 17403 Phone: 717-741-8003 Fax: 717-741-8016 |